Pharma Journalist -

Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. The vaccine candidate,…
Read More...

Sangamo Therapeutics, Inc. announced that it has executed a global licensing collaboration agreement with Novartis to develop and commercialize gene regulation therapies to address…
Read More...

Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies. The data, published…
Read More...

Harbour BioMed (HBM) and Viva Biotech (Shanghai) Ltd. announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and…
Read More...

UCB announced an agreement to enter into a world-wide, exclusive license agreement with Roche and Genentech, a member of the Roche Group, for the global development and…
Read More...

Piramal Pharma Solutions announced that it is providing Bolt Biotherapeutics (Bolt) with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing…
Read More...

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, and Celonic Group, a premium biopharmaceutical contract development and…
Read More...

At the direction of President Donald J. Trump, U.S. International Development Finance Corporation (DFC) Chief Executive Officer Adam Boehler will today sign a letter of interest (LOI)…
Read More...

Karuna Therapeutics, Inc. an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with…
Read More...

Viva Biotech Holdings and Schrödinger, Inc. announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of…
Read More...